Ibdclub| December 2022| Pregnancy and antiTNF

Kajali Mishra 3rd year Fellow Loyola University Benefits and Risks Associated With Continuation of Anti–Tumor Necrosis Factor After 24 Weeks of Pregnancy in Women With Inflammatory Bowel Disease https://doi.org/10.7326/M22-0819